Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contrast-associated nephropathy.

G A Porter1

  • 1Department of Medicine, Oregon Health Sciences University, Portland 97201.

The American Journal of Cardiology
|September 5, 1989
PubMed
Summary
This summary is machine-generated.

Contrast-associated nephropathy (CAN) is kidney damage after contrast dye exposure. Preexisting kidney disease and diabetes are key risk factors, with diabetes significantly increasing CAN incidence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abstracts of presentations to the Annual Meetings of the Canadian Society of Colon and Rectal Surgeons Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons: Canadian Surgery Forum, London, Ont., Sept. 19 to 22, 2002.

Canadian journal of surgery. Journal canadien de chirurgie·2023
Same author

Cross-Canada differences in early-stage breast cancer treatment and acute-care use.

Current oncology (Toronto, Ont.)·2019
Same author

ORE identifies extreme expression effects enriched for rare variants.

Bioinformatics (Oxford, England)·2019
Same author

First Report of White Mold (Sclerotinia sclerotiorum) on Soybean in Maine.

Plant disease·2019
Same author

The role of scientific evidence in decisions to adopt complex innovations in cancer care settings: a multiple case study in Nova Scotia, Canada.

Implementation science : IS·2019
Same author

Patterns of cancer centre follow-up care for survivors of breast, colorectal, gynecologic, and prostate cancer.

Current oncology (Toronto, Ont.)·2017
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Area of Science:

  • Nephrology
  • Radiology
  • Clinical Medicine

Background:

  • Contrast nephropathy, or contrast-associated nephropathy (CAN), is acute kidney injury following contrast material exposure.
  • Incidence rates vary widely (0-22%) due to differing study designs and criteria for renal impairment.
  • Key risk factors include pre-existing renal disease and diabetes mellitus, with combined risk approaching 100%.

Purpose of the Study:

  • To define contrast nephropathy and its associated risk factors.
  • To describe the clinical presentation and diagnostic criteria for CAN.
  • To explore proposed pathophysiologic mechanisms and prevention strategies.

Main Methods:

  • Review of reported studies on contrast nephropathy incidence and risk factors.
  • Analysis of clinical presentation, including temporal relationship to contrast studies and serum creatinine changes.

Related Experiment Videos

  • Discussion of proposed pathophysiologic mechanisms and diagnostic procedures.

    • Main Results:

    • CAN is defined as renal impairment after contrast exposure, excluding other causes.
    • Serum creatinine levels >50% above baseline or rising ≥1 mg/dl within 24 hours are diagnostic.
    • Peak creatinine occurs 3-5 days post-procedure; oliguria in ~30% of cases. Monitoring serum creatinine is crucial for high-risk patients.

    Conclusions:

    • Preexisting renal disease and diabetes are significant risk factors for CAN.
    • The clinical presentation involves a temporal rise in serum creatinine post-contrast.
    • Prevention emphasizes using the least invasive diagnostic procedures available.